| Name | Title | Contact Details |
|---|
Therapy designed to address an unmet and growing need in the CNS and substance abuse space.
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow`s pipeline is led by SPI-62 in Phase 2 clinical development.
Northstar RX is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Greenwich Biosciences is the leader in researching cannabinoid medicines for rare epilepsies like Dravet Syndrome, LGS, TSC, and others.
Higher Dimension Research, Inc is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.